Home Search
- search results
If you're not happy with the results, please do another search
Blood test predicts how lymphoma respond to treatment
A blood test can predict which patients with a type of cancer called diffuse large B cell lymphoma are likely to respond positively to...
Experimental drug may help to prevent SOM
A new drug, called GC4419, although still in clinical trials, has already been designated by the US Food and Drug Administration as a "breakthrough...
Nigerian teens win major US tech innovation award
Five Nigerian teenagers have won a major tech innovation award in California for their app that spots fake drugs, reports the Mail & Guardian. Promise...
Low vaccination rates blamed for 'dramatic' surge in measles in Europe
A huge surge in measles across Europe has been reported by the World Health Organisation, which says low MMR vaccination rates are to blame....
Unpaywall transforms research as academic publishers start to crack
Unpaywall is a free service locates open-access articles and presents paywalled papers that have been legally archived and are freely available on other websites to...
Both low-carb and high-carb diets raise risk of early death — 25-year study
A large US study over 25 years indicates that moderate carb consumption – switching meat for plant-based protein and fats – is healthier than...
Predictor indicates the potential success of melanoma treatment
In a study, researchers developed a gene expression predictor that can indicate whether melanoma in a specific patient is likely to respond to treatment...
US opioid manufacturers feel the heat over 'deceptive marketing'
Opioid manufacturers are being inundated with lawsuits in the US, accusing the drug-makers of pushing addictive painkillers through deceptive marketing, with President Donald Trump raising...
Gauteng Health legal unit spends R94m on private lawyers
Gauteng Health spent R94m on private legal firms in the past year because its own legal unit could not cope. The Citizen reports that...
FDA approves Bristol-Myers Squibb lung cancer treatment
Bristol-Myers Squibb Co has announced that the US Food and Drug Administration approved its treatment, Opdivo, for patients whose lung cancer had progressed even...